Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia

F. Ravandi, C. Arana Yi, J. E. Cortes, M. Levis, S. Faderl, G. Garcia-Manero, E. Jabbour, M. Konopleva, S. O'Brien, Z. Estrov, G. Borthakur, D. Thomas, S. Pierce, M. Brandt, K. Pratz, R. Luthra, M. Andreeff, H. Kantarjian

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)1543-1545
Number of pages3
JournalLeukemia
Volume28
Issue number7
DOIs
StatePublished - Jul 2014
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia. / Ravandi, F.; Arana Yi, C.; Cortes, J. E.; Levis, M.; Faderl, S.; Garcia-Manero, G.; Jabbour, E.; Konopleva, M.; O'Brien, S.; Estrov, Z.; Borthakur, G.; Thomas, D.; Pierce, S.; Brandt, M.; Pratz, K.; Luthra, R.; Andreeff, M.; Kantarjian, H.

In: Leukemia, Vol. 28, No. 7, 07.2014, p. 1543-1545.

Research output: Contribution to journalLetter

Ravandi, F, Arana Yi, C, Cortes, JE, Levis, M, Faderl, S, Garcia-Manero, G, Jabbour, E, Konopleva, M, O'Brien, S, Estrov, Z, Borthakur, G, Thomas, D, Pierce, S, Brandt, M, Pratz, K, Luthra, R, Andreeff, M & Kantarjian, H 2014, 'Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia', Leukemia, vol. 28, no. 7, pp. 1543-1545. https://doi.org/10.1038/leu.2014.54
Ravandi, F. ; Arana Yi, C. ; Cortes, J. E. ; Levis, M. ; Faderl, S. ; Garcia-Manero, G. ; Jabbour, E. ; Konopleva, M. ; O'Brien, S. ; Estrov, Z. ; Borthakur, G. ; Thomas, D. ; Pierce, S. ; Brandt, M. ; Pratz, K. ; Luthra, R. ; Andreeff, M. ; Kantarjian, H. / Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia. In: Leukemia. 2014 ; Vol. 28, No. 7. pp. 1543-1545.
@article{2b950cff737645e1a7a2ae101c81c9c1,
title = "Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia",
author = "F. Ravandi and {Arana Yi}, C. and Cortes, {J. E.} and M. Levis and S. Faderl and G. Garcia-Manero and E. Jabbour and M. Konopleva and S. O'Brien and Z. Estrov and G. Borthakur and D. Thomas and S. Pierce and M. Brandt and K. Pratz and R. Luthra and M. Andreeff and H. Kantarjian",
year = "2014",
month = "7",
doi = "10.1038/leu.2014.54",
language = "English (US)",
volume = "28",
pages = "1543--1545",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia

AU - Ravandi, F.

AU - Arana Yi, C.

AU - Cortes, J. E.

AU - Levis, M.

AU - Faderl, S.

AU - Garcia-Manero, G.

AU - Jabbour, E.

AU - Konopleva, M.

AU - O'Brien, S.

AU - Estrov, Z.

AU - Borthakur, G.

AU - Thomas, D.

AU - Pierce, S.

AU - Brandt, M.

AU - Pratz, K.

AU - Luthra, R.

AU - Andreeff, M.

AU - Kantarjian, H.

PY - 2014/7

Y1 - 2014/7

UR - http://www.scopus.com/inward/record.url?scp=84904043013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904043013&partnerID=8YFLogxK

U2 - 10.1038/leu.2014.54

DO - 10.1038/leu.2014.54

M3 - Letter

C2 - 24487412

AN - SCOPUS:84904043013

VL - 28

SP - 1543

EP - 1545

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 7

ER -